Streamex Corp. — Director's Dealing 2024

Sep 13, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioSig Technologies, Inc. (BSGM)
CIK: 0001530766
Period of Report: 2024-09-11

Reporting Person: Amato Anthony N. (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-09-11	Common Stock	A	275000	—	Acquired	833202	Direct
2024-09-11	Common Stock	A	1275000	—	Acquired	2108202	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-09-11	Option (right to buy)	$0.4479	A	2400000	Acquired	2034-09-11	Common Stock (2400000)	Direct

Footnotes

F1: The shares of restricted stock were granted and fully vested as of September 11, 2024 (the "Date of Grant"), based on a closing price of $0.4479 per share on such date.

F2: The shares of restricted stock vest biannually over three years in equal installments with vesting commencing on the Date of Grant, based on the closing price of $.04479 per share on such date.

F3: The option to purchase shares of the Issuers common stock (the "Option") has an exercise price of $0.4479 per share. 1,200,000 of the Option vested and became exercisable on the Date of Grant and the remaining 1,200,000 unvested Option will vest bi-annually over the term of 3 years commencing on the Date of Grant, subject to continued service with the Company through each relevant vesting date.